PROCEPT BioRobotics (PRCT) Accumulated Expenses (2020 - 2026)

PROCEPT BioRobotics (PRCT) has reported Accumulated Expenses for 7 consecutive years, with $20.4 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Accumulated Expenses rose 25.4% year-over-year to $20.4 million in Q2 2026; TTM through Jun 2026 was $20.4 million, a 25.4% increase from a year earlier, with the FY2025 full-year figure at $23.2 million, up 7.61% from the prior year.
• Accumulated Expenses was $20.4 million for Q2 2026 at PROCEPT BioRobotics, up from $18.5 million in the prior quarter.
• Over five years, Accumulated Expenses peaked at $23.2 million in Q4 2025 and troughed at $4.6 million in Q1 2022.
• A 5-year average of $14.7 million and a median of $14.9 million in 2024 frame the typical range for Accumulated Expenses.
• Across the five-year window, Accumulated Expenses jumped 110.95% in 2022 and rose 7.61% in 2025, its largest moves.
• Over 5 years, Accumulated Expenses stood at $13.4 million in 2022, then rose by 25.57% to $16.9 million in 2023, then climbed by 27.55% to $21.5 million in 2024, then climbed by 7.61% to $23.2 million in 2025, then decreased by 11.79% to $20.4 million in 2026.
• The last three Accumulated Expenses figures came in at $20.4 million (Q2 2026), $18.5 million (Q1 2026), and $23.2 million (Q4 2025), per Business Quant data.